News | December 26, 2007

Study Results Urge Radiation Disclosure

December 27, 2007 – A new study examines how outpatient clinics that perform diagnostic procedures using radioactive materials could do a better job of telling patients that they may set off radiation detectors at security checkpoints.

There have been reports in the medical literature and the media of people activating such alarms and being questioned, and in some cases being strip-searched by security officials.
Radiation monitors are increasingly being used for security purposes, while millions of people undergo procedures involving radioactive material every year.

The Nuclear Regulatory Commission suggests that hospitals and clinics tell patients who have been given radiopharmaceuticals that they run the risk of triggering a radiation alarm, and that the facilities give them documentation to provide to law enforcement officials if necessary.

A person who has a bone, thyroid or heart scan with radioactive material, or cancer treatment with radioactive implants, can trigger a radiation alarm for days or even months after the procedure, depending on the type of radiopharmaceutical used.

The information and documentation that these facilities provide to patients vary widely in quality, said Dr. Armin Ansar. of the Radiation Studies Branch of the Centers for Disease Control and Prevention in Atlanta. "Some are extremely well done; some are not," he said.

The study, prepared by Dr. Ansari and his colleague, Dr. Luba Katz of Abt Associates in Cambridge, MA, appears in the Journal of Nuclear Medicine.

Just fewer two-thirds of those surveyed gave patients documentation; about one-third said they would provide it on request.

More than half of the healthcare professionals said they hadn't received training on communicating with patients about radiation risks, and two-thirds of these said they could benefit from such training.

For more information: www.nrc.gov

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...